The French launch of the type 2 diabetes mellitus combination treatment rosiglitazone/metformin [Avandamet] has been announced

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1469, 2005-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth Mary   Stein Stephanie Aleskow   Davis Stephen N  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2545-2554

Informa Healthcare

Access to resources Recommend Favorite

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes

By Del Prato Stefano   Volpe Laura  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1411-1422

Informa Healthcare

Access to resources Recommend Favorite

A fixed combination of rosiglitazone plus metformin improves glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

The oral antihyperglycaemic agent nateglinide [`Starlix'] has been approved in Switzerland for the treatment of type 2 diabetes mellitus.

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus

By Jaime A. Davidson  

Drug Safety, Vol. 27, Iss. 15, 2004-01 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite